• 25 September 2019
    Sequana Medical announces 2019 Half Year Results and Year-to-date Business Update

    Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces its business highlights and financial results for the six-month period ending 30 June 2019, prepared in accordance with IAS 34 Interim Financial Reporting as adopted by the European Union, and an outlook for the remainder of the year.

    Download the full press release